Cargando…
Fimasartan attenuates renal ischemia-reperfusion injury by modulating inflammation-related apoptosis
Fimasartan, a new angiotensin II receptor antagonist, reduces myocyte damage and stabilizes atherosclerotic plaque through its anti-inflammatory effect in animal studies. We investigated the protective effects of pretreatment with fimasartan on ischemia-reperfusion injury (IRI) in a mouse model of i...
Autores principales: | Cho, Jang-Hee, Choi, Soon-Youn, Ryu, Hye-Myung, Oh, Eun-Joo, Yook, Ju-Min, Ahn, Ji-Sun, Jung, Hee-Yeon, Choi, Ji-Young, Park, Sun-Hee, Kim, Chan-Duck, Kim, Yong-Lim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Physiological Society and The Korean Society of Pharmacology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205936/ https://www.ncbi.nlm.nih.gov/pubmed/30402026 http://dx.doi.org/10.4196/kjpp.2018.22.6.661 |
Ejemplares similares
-
NOX1 Inhibition Attenuates Kidney Ischemia-Reperfusion Injury via Inhibition of ROS-Mediated ERK Signaling
por: Jung, Hee-Yeon, et al.
Publicado: (2020) -
Alpha1-Antitrypsin Attenuates Renal Fibrosis by Inhibiting TGF-β1-Induced Epithelial Mesenchymal Transition
por: Cho, Jang-Hee, et al.
Publicado: (2016) -
Fimasartan-Based Blood Pressure Control after Acute Cerebral Ischemia: The Fimasartan-Based Blood Pressure Control after Acute Cerebral Ischemia Study
por: Hong, Keun-Sik, et al.
Publicado: (2021) -
The influence of dietary sodium content on the pharmacokinetics and pharmacodynamics of fimasartan
por: Gu, Namyi, et al.
Publicado: (2016) -
Dipeptidyl peptidase-4 inhibitor gemigliptin protects against vascular calcification in an experimental chronic kidney disease and vascular smooth muscle cells
por: Choi, Soon-Youn, et al.
Publicado: (2017)